Modern Healthspan cover image

Modern Healthspan

Taurine Next Steps For Human Trials | Prof Vijay Yadav Ep4

Aug 24, 2023
Prof Vijay Yadav discusses upcoming human trials for taurine and identifying therapeutic targets for metabolic disorders. They delve into taurine deficiency's role in aging, the need for comprehensive clinical trials, and the potential of personalized anti-aging interventions with combinatorial approaches.
09:23

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Pilot studies planned for taurine dosage ranges over six months, aiming for larger placebo-controlled trials globally.
  • Taurine shows life extension potential akin to rapamycin in mice, suggesting it could be a significant anti-aging factor.

Deep dives

Clinical Trial Design and Taurine Dosage

Pilot studies are being planned to define healthy taurine dosage ranges over six months to a year, with subsequent larger placebo-controlled trials across various countries to assess impacts on health span. Collaborating with clinicians globally, the aim is to establish rigorous study designs mirroring animal trials for a comprehensive investigation into taurine's health benefits.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode